{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:05:28Z","timestamp":1756339528864,"version":"3.44.0"},"reference-count":12,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,12,2]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>Thrombocytopaenia is a commonly encountered finding in hospitalised patients. Many antibiotics, especially beta-lactams, are well known to cause thrombocytopaenia by an immune-mediated mechanism. We present a 55-year-old woman who was admitted to the hospital with a complicated urinary tract infection resulting in right-sided pyonephrosis and pararenal abscess. She was observed to develop thrombocytopaenia after initiation of cefepime therapy. Following an extensive work-up for her new-onset thrombocytopaenia, she was diagnosed as a case of a drug (cefepime)-induced thrombocytopaenia. Her platelet count recovered back to normal levels after cessation of cefepime therapy. Based on our PubMed search, there are only a few cases of cefepime-induced thrombocytopaenia published in the literature. This paper illustrates that physicians should include cefepime among the possible aetiologies of thrombocytopaenia. Additionally, this article outlines the currently available approaches to the diagnosis and management of drug-induced thrombocytopaenia.<\/jats:p>","DOI":"10.1136\/bcr-2021-243749","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T10:46:00Z","timestamp":1642416360000},"page":"e243749","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Cefepime: a novel cause of thrombocytopaenia"],"prefix":"10.1136","volume":"15","author":[{"given":"Shoaib","family":"Muhammad","sequence":"first","affiliation":[{"name":"Urology, Gulab Devi Chest Hospital, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soban","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Emergency Medicine, Department of Medical Education, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behram Ahmed","family":"Khan","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center, Omaha, Nebraska, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0646-508X","authenticated-orcid":false,"given":"Amman","family":"Yousaf","sequence":"additional","affiliation":[{"name":"Internal Medicine, McLaren Health Care Corporation, Flint, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"2025082709252803000_15.1.e243749.1","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s11096-011-9571-5","article-title":"Cefepime-associated thrombocytopenia in a critically ill patient","volume":"33","author":"Lim","year":"2011","journal-title":"Int J Clin Pharm"},{"key":"2025082709252803000_15.1.e243749.2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"2025082709252803000_15.1.e243749.3","unstructured":"Greene EM , Hagemann TM . Drug-induced hematologic disorders. In: DiPiro JT , Talbert RL , Yee GC , et al , eds. Pharmacotherapy: a pathophysiologic approach. 10th edn. New York, NY: McGraw-Hill Education, 2017."},{"key":"2025082709252803000_15.1.e243749.4","doi-asserted-by":"publisher","DOI":"10.1177\/106002809502900901"},{"key":"2025082709252803000_15.1.e243749.5","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200326100-00003"},{"key":"2025082709252803000_15.1.e243749.6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-77-3-401"},{"key":"2025082709252803000_15.1.e243749.7","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.40.6.700-a"},{"key":"2025082709252803000_15.1.e243749.8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00277-009-0872-x","article-title":"Hematoma of the iliopsoas muscle due to thrombocytopenia resulting from the administration of a third-generation cephalosporin","volume":"89","author":"Onodera","year":"2010","journal-title":"Ann Hematol"},{"key":"2025082709252803000_15.1.e243749.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2007.06.005"},{"key":"2025082709252803000_15.1.e243749.10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1537-2995.2004.03378.x","article-title":"Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells","volume":"44","author":"Gro\u00dfjohann","year":"2004","journal-title":"Transfusion"},{"key":"2025082709252803000_15.1.e243749.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-5231(03)00100-X"},{"key":"2025082709252803000_15.1.e243749.12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/039139880502800506","article-title":"Plasma therapies in thrombotic syndromes","volume":"28","author":"Nguyen","year":"2005","journal-title":"Int J Artif Organs"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-243749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:25:33Z","timestamp":1756311933000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-243749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,17]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/bcr-2021-243749"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-243749","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}